Get Email Updates from NBT

Processing…
Success! You're on the list.
Business Reporter at New Brunswick Today
dschatz@nb.today

Dave is an award-winning business reporter who has authored over 200 articles for New Brunswick Today.

Posted inBusiness & Labor

FedEx Dumps Amazon as Package Delivery Continues to Evolve

NEW BRUNSWICK, NJ—This holiday season will be the first where Federal Express, better known as FedEx, won’t be delivering at least some packages for Amazon, the nation’s largest online retailer. With more and more shipments being delivered amid online retail growth, parcel delivery and pick-up continues to evolve. Increasingly, Amazon is delivering its own packages […]

Posted inLaw & Public Safety, Business & Labor, Healthcare

Johnson & Johnson Ordered to Pay $572 Million in Oklahoma Opioid Case

NORMAN, OK—A judge suggested that Johnson & Johnson was the kingpin of Oklahoma’s opioid crisis on August 26, ordering the New Brunswick-based pharmaceutical giant to pay $572 million to fix the ravage the epidemic has caused the state’s residents. The verdict could be a warning to other drug companies facing similar cases in courts across […]

Posted inBusiness & Labor, Arts & Culture, Transportation

New Biergarten Set to Open Next to Train Station This August

NEW BRUNSWICK, NJ—The New Brunswick Parking Authority (NBPA) found a tenant for the space that previously housed Brother Jimmy’s Barbecue at 5 Easton Avenue. After months of delays, Redd’s Biergarten is tentatively set for a “soft opening” in mid-August, according to the NBPA Executive Director’s report to his Board of Commissioners on July 24. “I’m […]

Posted inHealthcare

Between Baby Powder and Opioid Lawsuits, J&J Says It Will Defend Itself in About 16,000 Cases

JOHNSON & JOHNSON BATTLES LAWSUITS OVER TALC-BASED BABY POWDER AND PROMOTING ADDICTIVE OPIOID DRUGS NEW BRUNSWICK, NJ–Johnson & Johnson (J&J) is now the subject of a U.S. Justice Department (DOJ) probe into whether it lied to consumers regarding potential cancer risks of its namesake talc-based baby powder, according to reports.  Yet the Hub City-based health-care […]

Posted inArchive

Protests at Annual Meeting Target J&J Over Cost of Tuberculosis Drug

NEW BRUNSWICK, NJ–About 50 protesters uniformly filled Albany Street on April 25 for the annual Johnson & Johnson (J&J) shareholders meeting to convey a message: The price of bedaquiline, a lifesaving tuberculosis (TB) drug sold by J&J, should be no more than a dollar a day.

They chanted in succession, “Pills cost pennies. Greed costs lives,” while most held one or more pill bottles as props.